Literature DB >> 17268216

Explicit and implicit evaluation of physician adherence to hypertension guidelines.

Gail Ardery1, Barry L Carter, Jessica L Milchak, George R Bergus, Jeffrey D Dawson, Paul A James, Carrie Franciscus, Yoonsang Kim.   

Abstract

This study evaluated physician adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) hypertension guidelines in 6 community-based clinics. Explicit review of retrospective medical record data for patients with uncontrolled hypertension measured guideline adherence using 22 criteria. Mean overall guideline adherence was 53.5% and did not improve significantly over time. Random-effects models demonstrated significant associations between guideline adherence and various demographic and medical predictors, including age, minority status, comorbid conditions, and number of medications. A subsequent implicit review evaluated the degree to which nonadherence was justifiable and identified factors that might have affected adherence. Nonadherence was rated as justifiable for only 6.6% of the failed explicit criteria. In general, adherence to the JNC 7 guidelines was modest even when barriers that might have affected adherence were taken into consideration.

Entities:  

Mesh:

Year:  2007        PMID: 17268216      PMCID: PMC8110017          DOI: 10.1111/j.1524-6175.2007.06112.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

1.  Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.

Authors:  D J Naiman; L R Barker
Journal:  Md Med J       Date:  1999 Nov-Dec

2.  Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.

Authors:  K Tom Xu; Michael Moloney; Sidney Phillips
Journal:  Am J Manag Care       Date:  2003-08       Impact factor: 2.229

3.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers.

Authors:  J Minami; T Ishimitsu; H Matsuoka
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

5.  The relationship of physicians' medical recording performance to their medical care performance.

Authors:  T F Lyons; B C Payne
Journal:  Med Care       Date:  1974-08       Impact factor: 2.983

6.  Problems with medical records.

Authors:  H M Tufo; J J Speidel
Journal:  Med Care       Date:  1971 Nov-Dec       Impact factor: 2.983

7.  Trends in medication choices for hypertension in the elderly. The decline of the thiazides.

Authors:  M Monane; R J Glynn; J H Gurwitz; R L Bohn; R Levin; J Avorn
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

8.  Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy.

Authors:  C Cuspidi; I Michev; L Lonati; A Vaccarella; M Cristofari; G Garavelli; G Palumbo; S Meani; G Leonetti; F Magrini; A Zanchetti
Journal:  J Hum Hypertens       Date:  2002-10       Impact factor: 3.012

9.  Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians.

Authors:  C R Nelson; D A Knapp
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

10.  Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.

Authors:  D Siegel; J Lopez; J Meier; F Cunningham
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

View more
  28 in total

1.  A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Authors:  Barry L Carter; William Clarke; Gail Ardery; Cynthia A Weber; Paul A James; Mark Vander Weg; Elizabeth A Chrischilles; Thomas Vaughn; Brent M Egan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-07

2.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

3.  Conflicting influences on UK mothers' decisions to introduce solid foods to their infants.

Authors:  Madelynne A Arden
Journal:  Matern Child Nutr       Date:  2010-04       Impact factor: 3.092

4.  Cost of Unnecessary Amylase and Lipase Testing at Multiple Academic Health Systems.

Authors:  Jacob P Ritter; Federico M Ghirimoldi; Laura S M Manuel; Eric E Moffett; Thomas J Novicki; James C McClay; Paula K Shireman; Bradley B Brimhall
Journal:  Am J Clin Pathol       Date:  2020-02-08       Impact factor: 2.493

5.  Sustained blood pressure control following discontinuation of a pharmacist intervention.

Authors:  Danielle M Wentzlaff; Barry L Carter; Gail Ardery; Carrie L Franciscus; William R Doucette; Elizabeth A Chrischilles; Kurt A Rosenkrans; Lucinda M Buys
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

6.  Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.

Authors:  Barry L Carter; William R Doucette; Carrie L Franciscus; Gail Ardery; Karen M Kluesner; Elizabeth A Chrischilles
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

7.  Documented lifestyle education among young adults with incident hypertension.

Authors:  Heather M Johnson; Andrea G Olson; Jamie N LaMantia; Amy J H Kind; Nancy Pandhi; Eneida A Mendonça; Mark Craven; Maureen A Smith
Journal:  J Gen Intern Med       Date:  2014-11-06       Impact factor: 5.128

8.  When tight blood pressure control is not for everyone: a new model for performance measurement in hypertension.

Authors:  Michael A Steinman; Mary K Goldstein
Journal:  Jt Comm J Qual Patient Saf       Date:  2010-04

9.  The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.

Authors:  James L Pool; Robert Glazer; Nora Crikelair; Drew Levy
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Physician and pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; Gail Ardery; Jeffrey D Dawson; Paul A James; George R Bergus; William R Doucette; Elizabeth A Chrischilles; Carrie L Franciscus; Yinghui Xu
Journal:  Arch Intern Med       Date:  2009-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.